ScinoPharm Taiwan Ltd
TWSE:1789
ScinoPharm Taiwan Ltd
Unrealized Security Profit/Loss
ScinoPharm Taiwan Ltd
Unrealized Security Profit/Loss Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Unrealized Security Profit/Loss | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Unrealized Security Profit/Loss
-NT$97.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Unrealized Security Profit/Loss
NT$39.7m
|
CAGR 3-Years
44%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Unrealized Security Profit/Loss
-NT$2.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Unrealized Security Profit/Loss
NT$10.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Unrealized Security Profit/Loss
-NT$117.7m
|
CAGR 3-Years
24%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Unrealized Security Profit/Loss
NT$103.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
ScinoPharm Taiwan Ltd
Glance View
ScinoPharm Taiwan Ltd. engages in the research, development, manufacturing, and sales of active pharmaceutical ingredients and injections. The company is headquartered in Tainan, Tainan. The company went IPO on 2010-10-29. The main products include active pharmaceutical ingredients, protein drugs, oligonucleotides, peptides, injection preparations, new small molecule drugs and other chemical raw materials. The firm is also engaged in the provision of consulting and biotechnology services for related products, the international trading of products, as well as the provision of customized full-process services such as chemical molecular component synthesis, process development and commercial mass production. The firm operates within the domestic market and to overseas markets, including the Americas, Europe, Australia and Asia.
See Also
What is ScinoPharm Taiwan Ltd's Unrealized Security Profit/Loss?
Unrealized Security Profit/Loss
-97.5m
TWD
Based on the financial report for Dec 31, 2024, ScinoPharm Taiwan Ltd's Unrealized Security Profit/Loss amounts to -97.5m TWD.
What is ScinoPharm Taiwan Ltd's Unrealized Security Profit/Loss growth rate?
Unrealized Security Profit/Loss CAGR 1Y
0%
Over the last year, the Unrealized Security Profit/Loss growth was 0%.
You don't have any saved screeners yet